Posted by Michael Wonder on 08 Aug 2021
Additional COVID-19 treatment for Australia
8 August 2021 - The Australian Government has secured an initial shipment of over 7,700 doses of the novel monoclonal antibody treatment sotrovimab.
Sotrovimab is currently being assessed by the Therapeutic Goods Administration and will be available for use in Australia this year once the TGA evaluations are complete.
